{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:58:37Z","timestamp":1781247517048,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jchromb.2018.10.027","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T17:53:24Z","timestamp":1541008404000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometry"],"prefix":"10.1016","volume":"1105","author":[{"given":"Jesper","family":"Sundell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Birgersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"\u00c4bel\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt-J\u00fcrgen","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2018.10.027_bb0005","series-title":"Global Tuberculosis Report 2016","author":"World Health Organisation","year":"2016"},{"key":"10.1016\/j.jchromb.2018.10.027_bb0010","series-title":"Treatment of Tuberculosis Guidelines 2010","author":"World Health Organisation","year":"2010"},{"key":"10.1016\/j.jchromb.2018.10.027_bb0015","series-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection","year":"2016"},{"key":"10.1016\/j.jchromb.2018.10.027_bb0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1469-0691.2004.00758.x","article-title":"Tuberculosis in HIV-infected patients: a comprehensive review","volume":"10","author":"Aaron","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0025","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2165\/00003495-200666180-00003","article-title":"Tuberculosis and HIV co-infection: a practical therapeutic approach","volume":"66","author":"Breen","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2018.10.027_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.11604\/pamj.2016.25.167.10060","article-title":"First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors","volume":"25","author":"Bouazzi","year":"2016","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1164\/rccm.200411-1557OC","article-title":"The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis","volume":"172","author":"Sirgel","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0040","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/rcm.2100","article-title":"A liquid chromatography\/tandem mass spectrometry method for the simultaneous quantification of isoniazid and ethambutol in human plasma","volume":"19","author":"Chen","year":"2005","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0045","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.jchromb.2009.04.038","article-title":"Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography-tandem mass spectrometry","volume":"877","author":"de Velde","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0050","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jchromb.2009.04.023","article-title":"A rapid and robust liquid chromatography\/tandem mass spectrometry method for simultaneous analysis of anti-tuberculosis drugs\u2014ethambutol and pyrazinamide in human plasma","volume":"877","author":"Gong","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpba.2014.09.019","article-title":"Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study","volume":"102","author":"Hee","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/chromsci\/bmx016","article-title":"Simultaneous LC-MS-MS determination of lopinavir and rifabutin in human plasma","volume":"55","author":"Jaiswal","year":"2017","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpba.2014.08.026","article-title":"Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"102","author":"Kim","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0070","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/apm.12590","article-title":"Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography\/tandem mass spectrometry","volume":"124","author":"Prahl","year":"2016","journal-title":"Acta Pathol. Microbiol. Immunol. Scand."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jchromb.2016.02.036","article-title":"An improved LC-MS\/MS method for the simultaneous determination of pyrazinamide, pyrazinoic acid and 5-hydroxy pyrazinoic acid in human plasma for a pharmacokinetic study","volume":"1017\u20131018","author":"Shah","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0080","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/rcm.2961","article-title":"Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography\/tandem mass spectrometry","volume":"21","author":"Song","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpba.2012.05.028","article-title":"Quantification of rifampicin in human plasma and cerebrospinal fluid by a highly sensitive and rapid liquid chromatographic-tandem mass spectrometric method","volume":"70","author":"Srivastava","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jpba.2014.11.011","article-title":"Determination of the rifamycin antibiotics rifabutin, rifampin, rifapentine and their major metabolites in human plasma via simultaneous extraction coupled with LC\/MS\/MS","volume":"104","author":"Winchester","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0095","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1007\/s00216-013-7049-0","article-title":"Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma","volume":"405","author":"Zhou","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0100","series-title":"Guidance for Industry Bioanalytical Method Validation","year":"2013"},{"key":"10.1016\/j.jchromb.2018.10.027_bb0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpba.2005.11.006","article-title":"A new approach to evaluate regression models during validation of bioanalytical assays","volume":"41","author":"Singtoroj","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0110","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0115","series-title":"Population Pharmacokinetic Modeling of Efavirenz in Rwandan Adult Patients on Concomitant HIV and Tuberculosis Treatments (manuscript)","author":"Bienvenu","year":"2013"},{"key":"10.1016\/j.jchromb.2018.10.027_bb0120","first-page":"1360","article-title":"Pharmacokinetics of ethambutol in children and adults with tuberculosis","volume":"8","author":"Zhu","year":"2004","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00558302","article-title":"Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects","volume":"36","author":"Lacroix","year":"1989","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0130","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1093\/jac\/dkv268","article-title":"Population pharmacokinetics of rifampicin and 25-deacetyl-rifampicin in healthy Asian adults","volume":"70","author":"Seng","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0135","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1128\/AAC.01244-15","article-title":"Population pharmacokinetic analysis of isoniazid, acetylisoniazid, and isonicotinic acid in healthy volunteers","volume":"59","author":"Seng","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2018.10.027_bb0140","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02625-16","article-title":"Population pharmacokinetics of pyrazinamide in patients with tuberculosis","volume":"61","author":"Alsultan","year":"2017","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023218309218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023218309218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T23:50:40Z","timestamp":1548805840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023218309218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":28,"alternative-id":["S1570023218309218"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.10.027","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}